A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (RomvimzaTM) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue ...

Study identifies 380 inherited genetic variants linked to cancer risk, paving the way for improved screening and treatments.